The weekly litigation news digest is live. Subscribe now

IP Verse

Modulation Of Afucosylated Species In A Monoclonal Antibody Composition - EP3400241

The patent EP3400241 was granted to Oncobiologics on Jul 22, 2020. The application was originally filed on Jan 5, 2017 under application number EP17702444A. The patent is currently recorded with a legal status of "Revoked".

EP3400241

ONCOBIOLOGICS
Application Number
EP17702444A
Filing Date
Jan 5, 2017
Status
Revoked
Apr 29, 2022
Publication Date
Jul 22, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBApr 21, 2021LAHRTZADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS6090382
INTERNATIONAL-SEARCH-REPORTWO2010141855
INTERNATIONAL-SEARCH-REPORTWO2012041768
INTERNATIONAL-SEARCH-REPORTWO2013114165
INTERNATIONAL-SEARCH-REPORTWO2014055370
INTERNATIONAL-SEARCH-REPORTWO2015140700
OPPOSITIONWO2005089182
OPPOSITIONWO2006125821
OPPOSITIONWO2007115813
OPPOSITIONWO2010141478
OPPOSITIONWO2010141855
OPPOSITIONWO2012041768
OPPOSITIONWO2014055370

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents